Fundraising Fox
EnteroTrack
Aurora, US · Founded 2013 · Colorado LLC · 15 employees on LinkedIn
Find your way into EnteroTrack
Sign up to see every warm intro you have to EnteroTrack
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EnteroTrack team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
Founders & leadership
EnteroTrack was founded in 2013 by Robin Shandas.
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 3 rounds · 2014–2026
▶$2MraisedSep 2026 · 4 investors · BiotechnologyRule 506(b)
- Robin ShandasExecutive Officer, Director
- Glenn T. FurutaDirector
- Steven J. AckermanDirector
- Jeffrey HarringtonDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Sep 2026
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$4.7MraisedJun 2021 · 1 investors · BiotechnologyRule 506(b)
- Jeffrey HarringtonDirector
- Steven AckermanDirector
- Robin ShandasExecutive Officer, Director
- Glenn FurutaDirector
- Offering amount
- $4.7M
- Amount sold
- $4.7M
- First sale
- May 2021
- Incorporated
- Limited Liability Company, Colorado
- Federal exemptions
- 06b
▶$250KraisedJul 2014 · 1 investors · BiotechnologyRule 506(b)
- Steven AckermanDirector
- Robin ShandasDirector
- Glenn FurutaDirector
- Offering amount
- $500K
- Amount sold
- $250K
- Minimum investment
- $250K
- First sale
- May 2014
- Incorporated
- Limited Liability Company, Colorado, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as EnteroTrack.
Frequently asked questions
- What does EnteroTrack do?
- EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
- Who founded EnteroTrack?
- EnteroTrack was founded by Robin Shandas in 2013.
- How much funding has EnteroTrack raised?
- EnteroTrack has disclosed $6.9M raised across 3 rounds.
- Where is EnteroTrack headquartered?
- EnteroTrack is headquartered in Aurora, US.